Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

921 studies match

clinicaltrialsPublishedShowing 901–921 of 921 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00057720	TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer	completed	Phase 3	440	TelikINDUSTRY	13	Jul 25, 2011	clinicaltrials
NCT00094653	MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma	completed	Phase 3	1,783	Bristol-Myers SquibbINDUSTRY	13	Jul 11, 2011	clinicaltrials